Merck cutting 8,500 jobs in massive R&D, commercial shakeup

Merck & Co. is cutting 8,500 jobs and jettisoning some research and development programs as the big drug maker refocuses its strategy and moves to save $2.5 billion a year in annual costs.

More from Alimentary/Metabolic

More from Therapy Areas